PACIRA BIOSCIENCES, INC.
Ownership & governance
Executives 5Directors 9Avg age 59Avg tenure 3.8y
FL
Frank Lee
Chief Executive Officer
Age 58Since 2024-01-01Profile →
+13
Executives5
Board of directors9
LB
Laura Brege→
Chairman
Age 68Since 2025-01-27
MF
Mark Froimson→
Director/Board Member
Age 65Since 2017-06-14
CC
Christopher Christie→
Director/Board Member
Age 63Since 2019-09-17
MB
Marcelo Bigal→
Director/Board Member
Age 56Since 2023-10-09
MY
Michael Yang→
Director/Board Member
Age 64Since 2023-10-09
AY
Alethia Young→
Director/Board Member
Age 47Since 2023-10-09
FL
Frank Lee→
Director/Board Member
Age 58Since 2024-01-01
SH
Samit Hirawat→
Director/Board Member
Age 57Since 2026-01-26
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| BlackRock Advisors LLC | 16.23 % | 6,384,387 |
| DOMA Perpetual Capital Management LLC | 7.062 % | 2,777,794 |
| Vanguard Portfolio Management LLC | 6.359 % | 2,501,286 |
| DFA Australia Ltd. | 5.138 % | 2,020,993 |
| D.E. Shaw & Co., Inc. | 5.041 % | 1,982,724 |
Catalog · 2026-07-09
Registry officers14
| Name | Role | Since | Shares |
|---|---|---|---|
| Frank Lee | Chief Executive Officer | 2024-01-01 | - |
| Jonathan Slonin | Chief Tech/Sci/R&D Officer | 2021-06-30 | - |
| Kristen Williams | Chief Administrative Officer | 2014-09-30 | - |
| Laura Brege | Chairman | 2025-01-27 | - |
| Shawn Cross | Director of Finance/CFO | 2024-10-20 | - |
| Alethia Young | Director/Board Member | 2023-10-09 | - |
| Christopher Christie | Director/Board Member | 2019-09-17 | - |
| Frank Lee | Director/Board Member | 2024-01-01 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus holdMean target 33.57Range 25–36.5Analysts 7
25Mean 33.5736.5
- Buy 1
- Hold 8
Broker actions40 of 210
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Truist Securities | Downgrade | Hold | 36.5 | 2026-10-09 |
| RBC Capital | Maintained | Sector Perform | 36.5 | 2026-10-09 |
| HC Wainwright & Co. | Downgrade | Neutral | 36.5 | 2026-10-09 |
| JP Morgan | Upgrade | Neutral | 36.5 | 2026-10-08 |
| Jefferies | Downgrade | Hold | 36 | 2026-10-08 |
| Needham | Downgrade | Hold | — | 2026-10-08 |
| Truist Securities | Maintained | Buy | 31 | 2026-10-07 |
| Oppenheimer | Initiated | Outperform | 32 | 2026-09-23 |
| Leerink Partners | Initiated | Market Perform | 28 | 2026-09-09 |
| RBC Capital | Maintained | Sector Perform | 25 | 2026-08-05 |
| Needham | Maintained | Buy | 33 | 2026-08-05 |
| HC Wainwright & Co. | Reiterated | Buy | 38 | 2026-07-01 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.